Verona Pharma
UKEntry
2019
Hold
6yr
Exit
2025
Who owns Verona Pharma?
Verona Pharma was owned by Sofinnova Partners through Sofinnova Crossover Fund I (2018 vintage) from 2019 to 2025, exited via Trade Sale. Across its history, Verona Pharma has been through 3 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Crossover Fund I · 2018 · VC
3 ownership periods · full history below
Key facts
Key takeaways
- ·Fully exited in 2025.
- ·Average hold across 2 realized cycles: 4 years.
Ownership history
3 ownership periods
Exited
Last exited in 2025 to .
Sofinnova PartnersExited 2025
2019 · 2025(6yr) · Sofinnova Crossover Fund I · 2018 · VC
Trade Sale · to
MOIC
–
AbingworthExited 2025
exited 2025 · Abingworth Bioventures VI · 2014 · Life Sciences VC
Trade Sale · to
MOIC
–
More from Sofinnova Crossover Fund I
Other portfolio companies in the same fund.
France
Sweden
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Verona Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Verona Pharma?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Verona Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue